Facebook Controversy Rating Downgraded by Analysts |
Equity Research & Insights |
Sustainalytics |
28/03/18 |
Sky Reports In-Line 9 Month Results |
Equity Research & Insights |
Allan C. Nichols, CFA |
20/04/17 |
Myth-busting: Stock Valuation and Earnings Growth |
Equity Research & Insights |
Dan Kemp |
27/03/17 |
What Do Morningstar Stock Ratings Mean? |
Morningstar News |
Morningstar |
15/02/16 |
Would You Invest in Technology and Social Media Stocks? |
Market Update |
Karen Kwok |
29/01/16 |
Stock in Focus: British American Tobacco |
Equity Research & Insights |
Philip Gorham |
30/07/14 |
Tesco and Vodafone Yield 5% |
Equity Research & Insights |
Morningstar Equity Analysts |
22/07/14 |
3 Stocks Screened for Profit |
Equity Research & Insights |
Emma Wall |
17/07/14 |
Market Update: Tech Stocks |
Market Update |
Peter Wahlstrom, CFA |
10/07/14 |
3 Undervalued Quality Stocks |
Equity Research & Insights |
Emma Wall |
10/07/14 |
Tullow Oil is Undervalued |
Equity Research & Insights |
Stephen Simko, CFA |
27/06/14 |
Undervalued Stock with Solid Yield |
Equity Research & Insights |
Jaime M. Katz, CFA |
26/06/14 |
3 European Stocks for Income |
Equity Research & Insights |
Emma Wall |
24/06/14 |
Brewer Dominates Emerging Markets |
Equity Research & Insights |
Philip Gorham |
23/06/14 |
Rolls Royce £1bn Share Buy-back |
Equity Research & Insights |
Daniel Holland |
20/06/14 |
Stock in Focus: HSBC |
Equity Research & Insights |
Erin Davis |
17/06/14 |
Stock in Focus: Apple |
Equity Research & Insights |
Brian Colello, CPA |
09/06/14 |
10 Stocks Bought by Top Fund Managers |
Equity Research & Insights |
Greggory Warren, CFA |
02/06/14 |
Money Printer Posts Profits |
Equity Research & Insights |
Brett Horn |
29/05/14 |
Astra, BP, Royal Mail and M&S |
The Week |
Rodney Hobson |
23/05/14 |
5 Market Dominating Stocks |
Equity Research & Insights |
Emma Wall |
01/05/14 |
Berkshire Hathaway Retains Strong Competitive Advantage |
Equity Research & Insights |
Greggory Warren, CFA |
30/04/14 |
Tobacco Offers Stable Income |
Equity Research & Insights |
Philip Gorham |
29/04/14 |
Analyst View: AstraZeneca Merger |
Equity Research & Insights |
Damien Conover, CFA |
28/04/14 |
Last Minute ISA Income Stocks |
Equity Research & Insights |
Emma Wall |
01/04/14 |
Sector in Focus: Energy Stocks |
Equity Research & Insights |
Emma Wall |
27/03/14 |
Most Overvalued FTSE Stock |
Equity Research & Insights |
Emma Wall |
26/03/14 |
Stock in Focus: Anglo American |
Equity Research & Insights |
Daniel Rohr, CFA |
25/03/14 |
Undervalued Stock with Prospects |
Equity Research & Insights |
R.J. Hottovy, CFA |
20/03/14 |
Is it Time to Sell these Stocks? |
Equity Research & Insights |
Emma Wall |
18/03/14 |
Fund Managers' Top 10 Income Stocks |
Equity Research & Insights |
Greggory Warren, CFA |
18/03/14 |
Undervalued Stock Has Wings |
Equity Research & Insights |
Philip Gorham |
06/03/14 |
BT Shares Worth £2.93 |
Equity Research & Insights |
Allan C. Nichols, CFA |
04/03/14 |
Top Managers' Favourite Small-Cap Stocks |
Equity Research & Insights |
Emma Wall |
20/02/14 |
Consumer Confidence Boosts Leisure Stocks |
Equity Research & Insights |
Emma Wall |
19/02/14 |
BHP Earnings Rise Not What it Seems |
Equity Research & Insights |
Mark Taylor |
19/02/14 |
Defence Cuts Threaten Rolls-Royce |
Equity Research & Insights |
Daniel Holland |
14/02/14 |
DIY Value Investment |
Equity Research & Insights |
Emma Wall |
13/02/14 |
Price Inflation Boosts Reckitt's Profit |
Equity Research & Insights |
Philip Gorham |
13/02/14 |
Cheap Treat for Value Investors |
Equity Research & Insights |
Emma Wall |
06/02/14 |
ICAP Pays 5.8% Yield |
Equity Research & Insights |
Michael Wong, CPA |
04/02/14 |
Diageo Secure Despite Profits Warning |
Equity Research & Insights |
Thomas Mullarkey, CFA |
31/01/14 |
Is Apple's Growth Hitting a Limit? |
Equity Research & Insights |
Jeremy Glaser |
29/01/14 |
XBox Sales Boost Microsoft |
Equity Research & Insights |
Norman Young |
28/01/14 |
Stock in Focus: Unilever |
Equity Research & Insights |
Erin Lash, CFA |
22/01/14 |
Investors Warned off Optimism |
The Week |
Rodney Hobson |
17/01/14 |
AstraZeneca now Overvalued |
Equity Research & Insights |
Emma Wall |
17/01/14 |
Stock in Focus: Standard Chartered |
Equity Research & Insights |
Erin Davis |
14/01/14 |
BAT Undervalued say Analysts |
Equity Research & Insights |
Thomas Mullarkey, CFA |
13/01/14 |
Undervalued Retail Stocks |
The Week |
Rodney Hobson |
10/01/14 |